Navigation Links
MiMedx Group, Inc. to Present at the 10th Annual Needham Healthcare Conference

MARIETTA, Ga., March 16, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it will present at the 10th Annual Needham Healthcare Conference in New York.  Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO of MiMedx, and John Daniel, President of Surgical Biologics, a wholly-owned subsidiary of MiMedx, are scheduled to present on Wednesday, April 6th, at 10:00 a.m. Eastern Time at the New York Palace Hotel in New York City.  A webcast of this presentation will be available on the Company's website,  

About the Company

MiMedx is an integrated developer, manufacturer and marketer of patent protected biomaterial-based products and bioimplants manufactured from human amniotic membrane. The Company is successfully emerging from a development-focused start-up into a fully integrated operating company with an experienced team poised to capitalize on its science and technology to generate rapid sales growth and profitability.  Our mantra is "Repair, don't replace" because our biochemists, engineers, designers and physicians believe it is better to augment repair when possible rather than replace traumatized, but otherwise healthy tissues and structures.  Our platform technologies, HydroFix™ and CollaFix™, and our newest platform technology, Purion® developed by our wholly-owned subsidiary, Surgical Biologics, have a vast number of potential applications in treating traumatized tissue and structures and MiMedx is focused on commercializing multiple applications for the Company's three technology platforms. In parallel, we are seeking strategic relationships, in selective categories, to more rapidly commercialize our technologies.  

SOURCE MiMedx Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MiMedx Announces Launch of AmnioFix™
2. MiMedx to Attend American Academy of Orthopedic Surgeons Annual Meeting
3. MiMedx Group, Inc. to Present at the 13th Annual Needham Growth Conference
4. MiMedx Group, Inc. Announces Release Date For Third Quarter Results
5. MiMedx Group, Inc. to Present at Noble Financial Sixth Annual Equity Conference
6. MiMedx Group Announces Temporary Trading Symbol Designation
7. Apexigen Announces the Filing by its Partner, Simcere Pharmaceutical Group, of First IND
8. Photonic Products Group, Inc. Announces New Sales and Marketing VP
9. Encorium Group, Inc. Announces New Business Contract Wins of $6.8 Million, Including Two Pivotal Phase III Studies for a Major Asian Technology Company
10. Anpath Group, Inc. Announces Fiscal 2010 Third Quarter Results
11. Encorium Group, Inc. Announces One-for-Eight Reverse Stock Split
Post Your Comments:
(Date:10/9/2015)... , ... October 09, 2015 , ... ... However, the current methods of separating those cells from their surroundings for research, ... to the cells. , To address this, Ann Arbor-based startup Akadeum Life ...
(Date:10/8/2015)... WEST PALM BEACH, Fla. , Oct. 8, 2015 ... a leader in synthetic biology, today announced the appointment ... President, Head of Environment Sector, succeeding Nir Nimrodi ... Corporate Development.  Mr. Vaillancourt will direct Intrexon,s endeavors to ... North America , where he held ...
(Date:10/8/2015)... 8, 2015  ATCC, the premier global biological materials ... been selected by The Michael J. Fox Foundation for ... academic, pharmaceutical, and biotechnology organizations committed to speed a ... United States , and more than 5 million ... United States , and more than 5 million ...
(Date:10/8/2015)... , October 8, 2015 ...   --> Goldman Small Cap Research, ... small cap and microcap sectors, announced today that ... on PharmaCyte Biotech, Inc. (OTCQB - PMCB), a ... developing and preparing treatments for cancer and diabetes. ...
Breaking Biology Technology:
(Date:9/30/2015)... 2015  The U.S. Court of Appeals for the ... in favor of Crossmatch ™, affirming the International ... Suprema and its U.S. partner Mentalix violated Section 337 ... that declares it unlawful to engage in "unfair practices" ... Crossmatch,s patents, the 5,900,993 patent and the 7,203,344 patent. ...
(Date:9/29/2015)... News facts: ... energy , Minimized design shrinks PC footprint ... and embedded Fujitsu PalmSecure authentication enable enterprises to realize ... shows that good things come in small packages, with ... enterprise desktop and mobile portfolio. Featuring workplace design that ...
(Date:9/28/2015)... , Sept. 28, 2015 ... today that its expedited traveler service is ... platform transforms travel, bringing a frictionless experience, ... members. "CLEAR offers our travelers ... customer service," said Jim Smith , ...
Breaking Biology News(10 mins):